Collection
Patient-Reported Outcomes in Neurology and Psychiatry
- Submission status
- Open
- Open for submission from
- 19 November 2021
- Submission deadline
- Ongoing
A collection of articles providing information on patient-reported outcomes in the management of neurological and psychiatric disorders.
Articles (7 in this collection)
-
-
Safety, Patient-Reported Well-Being, and Physician-Reported Assessment of Walking Ability in Patients with Multiple Sclerosis for Prolonged-Release Fampridine Treatment in Routine Clinical Practice: Results of the LIBERATE Study
Authors (first, second and last of 11)
- Giovanni Castelnovo
- Oliver Gerlach
- Joep Killestein
- Content type: Original Research Article
- Open Access
- Published: 28 July 2021
- Pages: 1009 - 1022
-
Efficacy, Retention and Tolerability of Everolimus in Patients with Tuberous Sclerosis Complex: A Survey-Based Study on Patients’ Perspectives
Authors (first, second and last of 38)
- Laurent M. Willems
- Felix Rosenow
- Adam Strzelczyk
- Content type: Original Research Article
- Open Access
- Published: 17 July 2021
- Pages: 1107 - 1122
-
Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study Report
Authors (first, second and last of 15)
- Emma Morton
- Venkat Bhat
- the CAN-BIND Investigator Team
- Content type: Original Research Article
- Published: 16 April 2021
- Pages: 439 - 450
-
Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies
Authors (first, second and last of 5)
- Joost J. Breeksema
- Alistair R. Niemeijer
- Robert A. Schoevers
- Content type: Systematic Review
- Open Access
- Published: 17 August 2020
- Pages: 925 - 946
-
Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine
Authors (first, second and last of 14)
- Jeremy Hobart
- Tjalf Ziemssen
- On behalf of the ENHANCE study investigators
- Content type: Original Research Article
- Open Access
- Published: 10 December 2018
- Pages: 61 - 79
-
Revisiting the Concept of Subjective Tolerability to Antipsychotic Medications in Schizophrenia and its Clinical and Research Implications: 30 Years Later
Authors
- A. George Awad
- Content type: Current Opinion
- Published: 03 December 2018
- Pages: 1 - 8